Article
The role of TP53 and p21 gene polymorphisms in breast cancer biology in a well specified and characterized German cohort.
Journal of cancer research and clinical oncology - 1 Sept 2010
Ebner Florian, Schremmer-Danninger Elisabeth, Rehbock Joachim
Abstract excerpt
OBJECTIVE: Abrogation of the function of TP53 gene is supposed to lead to a more aggressive breast cancer phenotype that produces a less favorable clinical outcome. The p21 gene on chromosome 6p21.2 can be stimulated by an activated TP53 gene. A product of transcription, the p21 protein, an inhibitor of cyclin-dependent kinases, has its function in gene repair and angiogenesis during cell division, and can...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
